Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Direxion Daily TSLA Bull 2X Shares (TSLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Direxion Daily TSLA Bull 2X Shares — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Direxion Daily TSLA Bull 2X Shares trades at $9.26 (market cap $3.77B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 8.2× Direxion Daily TSLA Bull 2X Shares's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Direxion Daily TSLA Bull 2X Shares pays none. Which is the better fit depends on your goals.
| GEHC | TSLL | |
|---|---|---|
Market Cap | $30.93B | $3.77B |
Volume | 5,033,451 | 58,292,886 |
Sector | Health | Leveraged / Inverse |
52-Week High | $88.16 | $23.03 |
52-Week Low | $59.48 | $6.74 |
Enterprise Value | $39.39B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 15 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
TSLL (Direxion Daily TSLA Bull 2X Shares ETF) trades at $10.00, down 1.48% on the day, with mixed technical signals showing a neutral overall outlook. The leveraged ETF tracks Tesla's daily performance, amplified by 2x, and benefits from recent Tesla momentum driven by Cybercab event anticipation. Key support and resistance cluster around $10-$11, with RSI indicators showing conflicting signals between short-term overbought conditions and neutral medium-term momentum.
As a leveraged ETF, TSLL carries inherent decay risks and is suitable only for short-term trading. The outlook depends entirely on Tesla's performance, with recent positive sentiment around Tesla's upcoming events providing potential upside. However, the leveraged structure makes it vulnerable to volatility decay, requiring careful risk management for investors considering exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Direxion Daily TSLA Bull 2X Shares
TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →
